Evaluate Safety and Effectiveness of XenoSure® Biological Patch in the Application of Peripheral Vascular Repair
← catalyst calendarSponsored by LeMaitre Vascular (industry) · LMAT — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · Single · Treatment
Enrollment
144estimated
Sites
1
Country
China
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2017-07-13 | actual | When the study began enrolling |
| Primary completion | 2025-11-15 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-11-15 | estimated | The whole study's end, after follow-up |
| First posted | 2017-06-02 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-03-10 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Vascular Diseases
Interventions
- Device: Implant the XenoSure patch
- Procedure: Repair/reconstruction of the diseased vessel
- Device: Implant the Vascular-Patch
Primary outcome
what the primary-completion date above is the date OFPrimary patency measured by ultrasound
measured 6 months
Permalink · LMAT's whole pipeline · Catalyst calendar · Every registered study · What changed